SynAct Pharma AB appointed Patrik Renblad as chief financial officer. Patrik joined SynAct Pharma as vice president finance in August 2021 and has more than 20 years of experience from different roles in large and mid-sized pharmaceutical companies, most recent LEO Pharma. Patrik worked in the interface between finance and business in all parts of the pharma value chain, from early research and development through manufacturing to commercial and importantly, business development.

Henrik Stage has been CFO since 2016, remains affiliated to SynAct as special advisor to the chief executive officer (CEO) until the company has been approved and initiated trading on Nasdaq main market in Stockholm.